Allegra is a brand name of fexofenadine, approved by the FDA in the following formulation(s):
ALLEGRA (fexofenadine hydrochloride - suspension; oral)
Manufacturer: SANOFI AVENTIS US
Approval date: October 16, 2006
Strength(s): 30MG/5ML [RLD]
Has a generic version of Allegra been approved?
No. There is currently no therapeutically equivalent version of Allegra available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Allegra. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Piperidine derivatives
Patent 5,578,610
Issued: November 26, 1996
Inventor(s): D'Ambra; Thomas E.
Assignee(s): Albany Molecular Research, Inc.
The present invention relates to substantially pure piperidine derivative compounds of the formulae: ##STR1## wherein R.sub.1 is hydrogen or hydroxy; R.sub.2 is hydrogen; or R.sub.1 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2 ; R.sub.3 is --COOH or --COOR.sub.4 ; R.sub.4 has 1 to 6 carbon atoms; A, B, and D are the substituents of their respective rings each of which may be different or the same and are hydrogen, halogens, alkyl, hydroxy, alkoxy, or other substituents. A process of preparing such piperidine derivative compounds in substantially pure form is also disclosed.Patent expiration dates:
- November 26, 2013✓
- November 26, 2013✓✓✓
- May 26, 2014✓✓
- November 26, 2013
Pharmaceutical composition for piperidinoalkanol compounds
Patent 5,738,872
Issued: April 14, 1998
Inventor(s): Ortyl; Thomas T. & Skultety; Paul F. & Mitchell; Kristen C. & Phadke; Deepak S. & Attarchi; Faraneh & Pierce; Marquerite L. & Schoeneman; Aaron W. & Schnitz; Joseph M.
Assignee(s): Hoechst Marion Roussel, Inc.
The invention provides a pharmaceutical composition in solid unit dosage form, comprising, a) a therapeutically effective amount of a piperidinoalkanol compound or a pharmaceutically acceptable salt thereof; and, b) at least one inert ingredient.Patent expiration dates:
- February 28, 2015
- August 28, 2015✓
- February 28, 2015
Pharmaceutical compositions for piperidinalkanol compounds
Patent 5,855,912
Issued: January 5, 1999
Inventor(s): Ortyl; Thomas T. & Skultety; Paul F. & Mitchell; Kristen C. & Phadke; Deepak S. & Attarchi; Faraneh & Pierce; Marguerite L. & Schoeneman; Aaron W. & Schnitz; Joseph M.
Assignee(s): Hoechst Marion Roussel, Inc.
The invention provides a pharmaceutical composition in solid unit dosage form, comprising, a) a therapeutically effective amount of a piperidinoalkanol compound or a pharmaceutically acceptable salt thereof; and, b) at least one inert ingredient.Patent expiration dates:
- February 28, 2015
- August 28, 2015✓
- February 28, 2015
Pharmaceutical composition for piperidinoalkanol compounds
Patent 5,932,247
Issued: August 3, 1999
Inventor(s): Ortyl; Thomas T. & Skultety; Paul F. & Mitchell; Kristen C. & Phadke; Deepak S. & Attarchi; Faraneh & Pierce; Marguerite L. & Schoeneman; Aaron W. & Schnitz; Joseph M.
Assignee(s): Hoechst Marion Roussel, Inc.
The invention provides a pharmaceutical composition in solid unit dosage form, comprising, a) a therapeutically effective amount of a piperidinoalkanol compound or a pharmaceutically acceptable salt thereof; and, b) at least one inert ingredient.Patent expiration dates:
- February 28, 2015
- August 28, 2015✓
- February 28, 2015
Method of providing an antihistaminic effect in a hepatically impaired patient
Patent 6,037,353
Issued: March 14, 2000
Inventor(s): Woodward; James K. & Okerholm; Richard A. & Eller; Mark G. & McNutt; Bruce E.
Assignee(s): Hoechst Marion Roussel, Inc.
The present invention relates to a method of providing an antihistaminic effect in a hepatically impaired patient in need thereof comprising administering to said patient an effective antihistaminic amount of a compound of the formula ##STR1## wherein R.sub.1 is hydrogen or hydroxy; R.sub.2 is hydrogen; or R.sub.1 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2 ; n is an integer of from 1 to 5; R.sub.3 is --COOH or --COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched; each of A and B is hydrogen or hydroxy with the proviso that at least one of A or B is hydrogen; or a pharmaceutically acceptable salt and individual isomers thereof.Patent expiration dates:
- March 14, 2017✓
- March 14, 2017✓
- September 14, 2017✓✓
- March 14, 2017
Pharmaceutical composition for piperidinoalkanol compounds
Patent 6,113,942
Issued: September 5, 2000
Inventor(s): Ortyl; Thomas T. & Skultety; Paul F. & Mitchell; Kristen C. & Phadke; Deepak S. & Attarchi; Faraneh & Pierce; Marguerite L. & Schoeneman; Aaron W. & Schnitz; Joseph M.
Assignee(s): Aventis Pharmaceuticals Inc.
The invention provides a pharmaceutical composition in solid unit dosage form, comprising, a) a therapeutically effective amount of a piperidinoalkanol compound or a pharmaceutically acceptable salt thereof; and, b) at least one inert ingredient.Patent expiration dates:
- February 28, 2015
- August 28, 2015✓
- February 28, 2015
Method of providing an antihistaminic effect in a hepatically impaired patient
Patent 6,187,791
Issued: February 13, 2001
Inventor(s): Woodward; James K. & Okerholm; Richard A. & Eller; Mark G. & McNutt; Bruce E.
Assignee(s): Merrell Pharmaceuticals Inc.
The present invention relates to a method of providing an antihistaminic effect in a hepatically impaired patient in need thereof comprising administering to said patient an effective antihistaminic amount of a compound of the formula ##STR1## wherein R.sub.1 is hydrogen or hydroxy; R.sub.2 is hydrogen; or R.sub.1 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2; n is an integer of from 1 to 5; R.sub.3 is --COOH or --COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched; each of A and B is hydrogen or hydroxy with the proviso that at least one of A or B is hydrogen; or a pharmaceutically acceptable salt and individual isomers thereof.Patent expiration dates:
- May 11, 2012✓
- May 11, 2012✓
- November 11, 2012✓✓
- May 11, 2012
Method of providing an antihistaminic effect in a hepatically impaired patient
Patent 6,399,632
Issued: June 4, 2002
Inventor(s): James K.; Woodward & Richard A.; Okerholm & Mark G.; Eller & Bruce E.; McNutt
Assignee(s): Merrell Pharmaceuticals Inc.
The present invention relates to a method of providing an antihistaminic effect in a hepatically impaired patient in need thereof comprising administering to said patient an effective antihistaminic amount of a compound of the formula wherein R1 is hydrogen or hydroxy; R2 is hydrogen; or R1 and R2 taken together form a second bond between the carbon atoms bearing R1 and R2; n is an integer of from 1 to 5; R3 is —COOH or —COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched; each of A and B is hydrogen or hydroxy with the proviso that at least one of A or B is hydrogen; or a pharmaceutically acceptable salt and individual isomers thereof.Patent expiration dates:
- May 11, 2012✓
- May 11, 2012✓
- November 11, 2012✓✓
- May 11, 2012
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
Patent 7,135,571
Issued: November 14, 2006
Inventor(s): Henton; Daniel R & McCarty; Frederick J & Tripp; Susan I & DeWitt; Jill E
Assignee(s): Aventis Pharmaceuticals, Inc.
The present invention is related to novel processes for preparing anhydrous and hydrated forms of piperidine derivatives, polymorphs and pseudomorphs thereof of the formulas which are useful as antihistamines, antiallergic agents and bronchodilators.Patent expiration dates:
- May 18, 2014✓
- November 18, 2014✓
- May 18, 2014
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
Patent 7,138,524
Issued: November 21, 2006
Inventor(s): McCarty; Frederick J. & Carr; Albert A.
Assignee(s): Aventis Pharmaceuticals, Inc.
The present invention is related to novel processes for preparing anhydrous and hydrated forms of piperidine derivatives, polymorphs and pseudomorphs thereof of the formulas which are useful as antihistamines, antiallergic agents and bronchodilators.Patent expiration dates:
- May 18, 2014✓
- November 18, 2014✓
- May 18, 2014
See also...
- Allegra Consumer Information (Drugs.com)
- Allegra Consumer Information (Wolters Kluwer)
- Allegra Suspension Consumer Information (Wolters Kluwer)
- Allegra Consumer Information (Cerner Multum)
- Allegra Advanced Consumer Information (Micromedex)
- Allegra AHFS DI Monographs (ASHP)
- Fexofenadine Consumer Information (Wolters Kluwer)
- Fexofenadine Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
- Fexofenadine Suspension Consumer Information (Wolters Kluwer)
- Fexofenadine Consumer Information (Cerner Multum)
- Fexofenadine Advanced Consumer Information (Micromedex)
- Fexofenadine Hydrochloride AHFS DI Monographs (ASHP)
No comments:
Post a Comment